advertisement
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 23
Showing records 1 to 23 | Display all abstracts in Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie121696 NADPH and NAC synergistically inhibits chronic ocular hypertension-induced neurodegeneration and neuroinflammation through regulating p38/MAPK pathway and peroxidation
Yu N
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 175: 116711
122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Sgambellone S
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454
121696 NADPH and NAC synergistically inhibits chronic ocular hypertension-induced neurodegeneration and neuroinflammation through regulating p38/MAPK pathway and peroxidation
Yu N
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 175: 116711
123803 YAP in development and disease: Navigating the regulatory landscape from retina to brain
Zhao Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 175: 116703
121696 NADPH and NAC synergistically inhibits chronic ocular hypertension-induced neurodegeneration and neuroinflammation through regulating p38/MAPK pathway and peroxidation
Wu X
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 175: 116711
122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Khanfar MA
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454
123803 YAP in development and disease: Navigating the regulatory landscape from retina to brain
Sun B
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 175: 116703
121696 NADPH and NAC synergistically inhibits chronic ocular hypertension-induced neurodegeneration and neuroinflammation through regulating p38/MAPK pathway and peroxidation
Zhang C
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 175: 116711
122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Marri S
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454
123803 YAP in development and disease: Navigating the regulatory landscape from retina to brain
Fu X; Zuo Z
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 175: 116703
121696 NADPH and NAC synergistically inhibits chronic ocular hypertension-induced neurodegeneration and neuroinflammation through regulating p38/MAPK pathway and peroxidation
Qin Q
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 175: 116711
122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Villano S
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454
123803 YAP in development and disease: Navigating the regulatory landscape from retina to brain
Qin H
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 175: 116703
122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Nardini P
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454
123803 YAP in development and disease: Navigating the regulatory landscape from retina to brain
Qin H; Qin H
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 175: 116703
121696 NADPH and NAC synergistically inhibits chronic ocular hypertension-induced neurodegeneration and neuroinflammation through regulating p38/MAPK pathway and peroxidation
Gu Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 175: 116711
123803 YAP in development and disease: Navigating the regulatory landscape from retina to brain
Yao K
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 175: 116703
122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Frank A
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454
121696 NADPH and NAC synergistically inhibits chronic ocular hypertension-induced neurodegeneration and neuroinflammation through regulating p38/MAPK pathway and peroxidation
Ke W; Liu X
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 175: 116711
122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Reiner-Link D; Stark H
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454
121696 NADPH and NAC synergistically inhibits chronic ocular hypertension-induced neurodegeneration and neuroinflammation through regulating p38/MAPK pathway and peroxidation
Zhang Q
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 175: 116711
122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Lucarini L
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454
121696 NADPH and NAC synergistically inhibits chronic ocular hypertension-induced neurodegeneration and neuroinflammation through regulating p38/MAPK pathway and peroxidation
Liu Z; Chen M; Wang K
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 175: 116711
